Division of Neuropsychology and Behavioral Neurology, Otto-von-Guericke-University, Magdeburg, Germany.
Restor Neurol Neurosci. 1999 Jan 1;14(2):109-14.
The present study aimed at the predictive value of early release patterns of protein S-100B and neuron specific enolase (NSE) in patients with traumatic brain injury. We investigated 69 patients who were admitted to the Department of Neurosurgery following traumatic brain injury. Both NSE and S-100B serum concentrations during the first three days after admission were highly and significantly correlated with Glasgow Coma and Coma Remission Scale scores at the respective blood sampling times as well as 2 weeks later. Signs of intracranial pathology as evaluated by CCT or MRI scans showed no association with NSE or S-100B release patterns. Our data support the hypothesis that NSE and protein S-100B are useful and sensitive neurobiochemical markers for the early clinical outcome of traumatic brain injury.
本研究旨在探讨创伤性脑损伤患者 S-100B 蛋白和神经元特异性烯醇化酶(NSE)早期释放模式的预测价值。我们调查了 69 名因创伤性脑损伤而入住神经外科的患者。入院后前三天的 S-100B 和 NSE 血清浓度与各自采血时间以及 2 周后的格拉斯哥昏迷和昏迷恢复量表评分高度显著相关。CCT 或 MRI 扫描评估的颅内病理迹象与 NSE 或 S-100B 释放模式无关。我们的数据支持这样的假设,即 NSE 和 S-100B 蛋白是创伤性脑损伤早期临床预后的有用且敏感的神经生化标志物。